Insider · CIK 0002118241
Manuella Carvalho Campos de Oliveira
Files at UGP (ULTRAPAR HOLDINGS INC). First filing -, latest -.
In brief
Manuella Carvalho Campos de Oliveira files SEC Form 4 as officer at UGP (ULTRAPAR HOLDINGS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Manuella Carvalho Campos de Oliveira has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | UGP ULTRAPAR HOLDINGS INC | AGrant or award Restricted Sharesderivative | +50,000 | $0.00 | $0 | 174,378 | 18 d ago |
| Apr 24, 2026 | UGP ULTRAPAR HOLDINGS INC | AGrant or award Restricted Sharesderivative | +9,082 | $0.00 | $0 | 124,378 | Apr 28, 2026 |
Questions about Manuella Carvalho Campos de Oliveira
Answered from the filings on this page, as of the latest one.
Is Manuella Carvalho Campos de Oliveira buying or selling?
Manuella Carvalho Campos de Oliveira has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Manuella Carvalho Campos de Oliveira's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Manuella Carvalho Campos de Oliveira has 0.
Where does Manuella Carvalho Campos de Oliveira file Form 4?
Manuella Carvalho Campos de Oliveira has filed Form 4 at UGP (ULTRAPAR HOLDINGS INC) as People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.